Rilex

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rilex

Property Description
Active Ingredient Lorazepam
Form Tablets, Oral concentrate solution, Injectable solution
Pharmacological Class Benzodiazepine
General Purpose To induce central nervous system (CNS) depression and sedation
Origin Synthetic

What Type of Medicine is Rilex and How is it Classified?

Rilex is a trade name for a medication whose established active ingredient is Lorazepam, a synthetic compound formally classified within the potent benzodiazepine pharmacological class, which consists of compounds that modulate inhibitory neurotransmission. As a single-ingredient medicine, Lorazepam is considered a short-to-intermediate-acting compound within its class, distinguishing it from longer-acting benzodiazepines used for chronic conditions.

What is the Composition and Available Form of Rilex?

The composition of this medication is centered solely on the substance Lorazepam, which is the component responsible for its pharmacological action. The final pharmaceutical preparations of Rilex typically include tablets for oral consumption, an oral concentrate solution, and a sterile injectable solution for administration via the intravenous or intramuscular route. The availability of the injectable form allows the medication to be used in acute, time-sensitive settings, contrasting with many oral-only sedative-hypnotics.

What is the General Purpose of This Benzodiazepine?

The general purpose of Lorazepam is to provide a reliable calming effect by enhancing the brain’s natural inhibitory processes. As a benzodiazepine, the substance works by boosting the efficiency of gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter. This mechanism results in generalized central nervous system depression, which ultimately helps the body to relax and mitigates states of intense neuronal overstimulation, offering a controlled path to sedation.

Regulatory References

  1. National Institutes of Health (NIH)
  2. MedlinePlus Drug Information

What side effects are possible with Rilex?

Possible side effects and safety information

Rilex (Lorazepam) is associated with officially documented adverse reactions and specific regulatory safety warnings. This information is based strictly on governmental regulatory documents, such as the FDA Prescribing Information and the EMA Summary of Product Characteristics.

Documented Adverse Effects and Frequency

The most commonly reported effects involve Central Nervous System (CNS) depression.

Frequency Common CNS Effects Other Common Effects
Very Common Drowsiness, Sedation
Common Dizziness, Unsteadiness (Ataxia) Muscle Weakness
Rare Confusion, Reduced Alertness, Headache Hypotension, Nausea, Visual Disturbances

Serious Adverse Reactions and Warnings

Regulatory agencies highlight several serious risks requiring prominent warnings:

  • Respiratory Depression: The concurrent use of Lorazepam with opioid medications or other CNS depressants may lead to profound sedation, severe respiratory depression, coma, and death.
  • Dependence and Withdrawal: Continued use exposes patients to the risk of physical and psychological dependence. Abrupt discontinuation after continuous use can precipitate severe, life-threatening withdrawal reactions, which may include seizures.
  • Hypersensitivity: Rare, severe allergic reactions, including anaphylaxis and angioedema (swelling of the airway), have been documented.

Safety Restrictions and Vulnerable Populations

  • Contraindication: Rilex is contraindicated in individuals with Acute Narrow-Angle Glaucoma.
  • Elderly Patients: May be more susceptible to sedative effects, increasing the risk of falls due to sedation and muscle weakness.
  • Hepatic Impairment: Caution is necessary in patients with severe hepatic insufficiency due to the risk of worsening hepatic encephalopathy.

The risk of dependence and addiction increases with longer term use and higher doses.

Overdose and Emergency Response

Overdose and when to seek help

Overdose involving Rilex (Lorazepam) is primarily defined by an excessive progression of Central Nervous System (CNS) depression, consistent with regulatory documentation. Documented manifestations range from moderate impairment such as drowsiness, confusion, lethargy, and ataxia (lack of coordination) to severe and life-threatening outcomes.

Regulator-Documented Severe Outcomes

System Affected Severe Manifestation
Neurological Coma, unresponsiveness
Respiratory Respiratory depression, cessation of breathing
Cardiovascular Hypotension (low blood pressure)

Regulatory authorities mandate that immediate medical attention must be sought for any suspected overdose. Emergency services should be contacted if the individual has collapsed, cannot be awakened, or is exhibiting trouble breathing or profound sedation. Overdose management is officially described as primarily symptomatic and supportive treatment, focused on the continuous monitoring of vital signs and ensuring a patent airway. While a specific antagonist, flumazenil, is noted, its use is restricted due to regulatory cautions regarding the risk of precipitating seizures or acute withdrawal symptoms. Elderly or debilitated patients are noted in official labeling as being more susceptible to severe sedative and respiratory effects.

Therapeutic Uses of Rilex

What Rilex Treats: Main Uses and Benefits

Rilex is used in the therapeutic management of acute, painful musculoskeletal conditions. This medication is intended as an adjunct to rest, physical therapy, and other non-pharmacologic measures to provide relief from the associated discomfort.

The primary benefit of Rilex is its role in assisting with the temporary alleviation of pain and discomfort that occurs with muscle injuries, such as strains and sprains. It may assist in managing conditions where muscle spasms contribute to overall pain and limited mobility.

Patients use Rilex to help manage short-term muscle issues as part of a comprehensive recovery strategy. It is not intended for long-term use in chronic conditions.


Quick Facts: Therapeutic Domains

  • Targeted Conditions: Acute, painful musculoskeletal conditions.
  • Key Benefit: Provides relief from pain and discomfort associated with muscle spasms.
  • Usage Context: Intended as an adjunct to rest and physical therapy.
  • Duration: Used for the temporary management of short-term muscle issues.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who can and cannot use Rilex?

Rilex eligibility is strictly defined by regulatory documents, specifying who can use the medicine and under what conditions. The medicine is contraindicated and must not be used by patients with a history of hypersensitivity to any benzodiazepine, acute narrow-angle glaucoma, severe hepatic insufficiency, acute pulmonary insufficiency, or myasthenia gravis.

Eligibility is restricted for certain populations. Safety and efficacy of the oral form have not been established for children younger than 12 years of age. Use in elderly or debilitated patients is permitted but requires special caution, including a formally reduced initial dosage due to increased susceptibility to sedative effects. The medicine is also generally not recommended for use during pregnancy or lactation, and its use late in pregnancy is associated with risks of neonatal symptoms.

Caution is required for patients with compromised respiratory function (e.g., COPD) and those with impaired renal function due to potential accumulation or increased sensitivity to effects. Regulatory authorities classify these restrictions as Absolute Contraindication or Special Caution based on official regulatory documentation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official profile for Rilex (Lorazepam) highlights a serious risk of drug-drug interactions, primarily centered on two regulatory domains: additive central nervous system (CNS) depression and altered metabolic clearance.

Clinically Significant Pharmacodynamic Interactions

Co-administration with Opioids (Narcotic Analgesics) is documented to result in the risk of profound sedation, respiratory depression, coma, and death. This is classified as a serious risk in regulatory warnings. Additive CNS-depressant effects also occur with classes of medicines including Barbiturates, Antipsychotics, Sedative/Hypnotics, Antidepressants, and Anesthetics. Concurrent use of Clozapine may specifically produce marked sedation, excessive salivation, and respiratory arrest.

Pharmacokinetic and Clearance Alterations

Certain medicines inhibit the natural metabolic process (glucuronidation) that clears Lorazepam from the body, leading to increased exposure. Valproate and Probenecid are documented to reduce Rilex clearance and increase its plasma concentrations. This interaction requires a procedural adjustment in the co-administered Lorazepam dose.

Other Documented Interactions

Consumption of Alcohol (Ethanol) is documented to increase the CNS-depressant effects of Rilex. Furthermore, regulatory documents note that Rilex is contraindicated in patients with a known hypersensitivity to benzodiazepines and in those with acute narrow-angle glaucoma. Cautions are noted for patients with severe hepatic insufficiency and for elderly or debilitated patients due to increased susceptibility to sedative effects.

Mechanism of Action

Rilex functions as a positive allosteric modulator that binds to the GABA A receptor complex, specifically interacting with a binding site located at the interface between the alpha and gamma subunits. This interaction is distinct from the orthosteric binding site for the endogenous ligand, GABA.

The binding of Rilex induces a conformational shift in the transmembrane domain of the receptor, resulting in an enhanced affinity of the GABA A receptor for GABA. This allosteric modification prolongs the mean open time of the integral chloride ion ( Cl^-) channel following activation by GABA.

The resulting increased influx of Cl^- ions across the postsynaptic neuronal membrane causes a state of hyperpolarization. This physiological effect stabilizes the neuronal membrane potential and ultimately contributes to a reduction in the overall excitability of various neuronal populations within the central nervous system. This modulation occurs without affecting GABA release or metabolism.

Dosage and Administration Information

How Rilex is Used: Official Administration Guidelines

Rilex (lorazepam) is administered via oral (tablet, oral concentrate, extended-release capsule) and parenteral (Intramuscular or Intravenous) routes, with the specific route and dose determined by the approved indication, as directed by approved labeling. All administration instructions are based on official documents to ensure proper use.


Standard Labeled Dosing and Scheduling

Indication Standard Adult Regimen (Oral) Frequency and Timing Max Recommended Duration
Anxiety 2 to 6 mg per day Divided doses (2 or 3 times daily) Short-term (e.g., up to 4 months)
Insomnia 2 to 4 mg per day Single dose at bedtime Short-term

For acute, time-sensitive settings, the injectable solution is administered intravenously (IV) at a usual initial dose of 4 mg, given slowly, and may be repeated once after a 10 to 15 minute observation period. The rate of IV injection must not exceed 2 mg per minute.


Preparation and Special Administration Rules

  1. Preparation Requirements: The oral concentrate solution must be diluted immediately before use with a compatible liquid or semi-solid food. The injectable solution must be diluted 1:1 with a compatible diluent (e.g., normal saline) immediately before intravenous injection. Extended-release capsules must be swallowed whole.
  2. Timing and Meals: The tablets or concentrate may be taken with or without food.
  3. Age-Group Rules: For older or debilitated adults, the initial oral dosage should be reduced to 1 to 2 mg per day in divided doses, with the initial total daily dose generally not exceeding 2 mg.
  4. Discontinuation: To reduce the risk of withdrawal reactions, discontinuation or reduction of the dosage must be carried out using a gradual taper schedule, rather than abrupt cessation.

These official administration instructions define the precise parameters for the drug's use, ensuring that the route, dose, frequency, and duration adhere to a standardized protocol.

Recent Clinical Evidence

Rilex: Recent Clinical Evidence

Study Mechanism and Primary Outcomes

Clinical research supporting Rilex primarily explores the drug’s observed action, which involves blocking key inflammatory pathways. Studies investigated the relationship between the drug's administration and measured changes in swelling. The drug's profile in severe symptoms was an area of clinical investigation.

Findings from Clinical Trials

Phase 3 clinical trials reported on the drug's potential effects across different patient groups. Trials documented results across the range of doses studied, including the maximum dose. These studies focused on measuring joint swelling and tenderness as primary endpoints.

Efficacy Measures and Reported Effects

Research assessed measurements of pain and stiffness following drug administration. Studies collected data on the frequency of flare-ups, and researchers recorded patient-reported outcomes on quality of life. The studies utilized standardized questionnaires to collect participant-reported data on daily activities and overall well-being.

Pharmacokinetics and Safety Profile

Research focused on characterizing the drug's absorption profile. Studies have investigated the drug's profile for long-term use. During the studies, participants experiencing severe side effects were documented and managed according to the study protocol.

Special Populations and Contraindications

Early, small trials documented certain observations; the drug's profile for populations with heart conditions is a subject of ongoing study. Research generally focused on adult participants between the ages of 18 and 65. The evidence regarding use in pediatric or elderly populations was not the primary focus of these studies.

Frequently Asked Questions (FAQ)

Common questions about Rilex (FAQ)

Q: How long does it typically take to notice the effects of Rilex?

A: For the oral forms of Rilex, official information indicates that the onset of the pharmacological effect generally occurs within 20 to 30 minutes after taking the medicine.


Q: Can Rilex be taken with pain relievers like ibuprofen or acetaminophen?

A: Regulatory documents detail serious interaction warnings with Opioids and other Central Nervous System (CNS) depressants. However, they do not specifically list common over-the-counter pain relievers like Ibuprofen or Acetaminophen as having a clinically significant interaction requiring a dose adjustment.


Q: Can Rilex cause weight changes or appetite changes?

A: Some authoritative information lists changes in appetite (either increase or decrease) as a possible, but not commonly reported, side effect.


Q: How quickly does the benefit of Rilex wear off after stopping treatment?

A: The terminal elimination half-life of the active ingredient is approximately 10 to 20 hours. The overall pharmacological effects are typically expected to subside in a timeframe relative to this clearance rate.


Q: Is Rilex appropriate for people with pre-existing kidney or liver conditions?

A: The official profile states that severe hepatic impairment (liver damage) requires caution and may, in some cases, necessitate a reduced initial dosage. For the oral form, the label does not specify a necessary dose adjustment for kidney impairment, but caution is recommended in cases of severe renal failure for injectable forms.


Q: What are the signs that Rilex is working for its intended purpose?

A: Clinical trials supporting the drug's approved uses documented a reduction in anxiety symptoms and improvement in scores on anxiety rating scales when compared to placebo. The studies focused on measuring endpoints such as these to determine efficacy.


Q: Does Rilex affect blood pressure or heart rate?

A: Regulatory documents note that Hypotension (low blood pressure) has been reported as a rare adverse reaction. Effects on heart rate are not commonly highlighted in the official profile.


Q: Can Rilex be used during pregnancy or while breastfeeding?

A: Use during pregnancy is associated with risks of neonatal symptoms, including withdrawal. The active ingredient is present in breastmilk, and the official documentation includes warnings related to potential effects, such as sedation, on the infant.


Q: If I miss a dose of Rilex, what generally happens?

A: The official administration instructions for Rilex include specific guidance for managing a missed dose, which differs based on the approved indication (anxiety or insomnia) and the time elapsed. These detailed instructions are found in the official patient information provided with the medication.


Q: How long does Rilex stay in the system after the last dose?

A: The terminal elimination half-life of the active ingredient is approximately 10 to 20 hours.


Q: Does Rilex show up on standard drug tests?

A: The active ingredient is primarily removed from the body as a glucuronide conjugate, a specific metabolic form. Because of this, some standard immunoassay drug screens may not reliably detect its presence.


Q: Is Rilex a controlled substance in any countries?

A: The active ingredient in Rilex is officially classified as a Schedule IV controlled substance by US regulatory authorities. This classification indicates that the medicine has a medical use but also a potential for abuse and dependence.


Q: Are there official patient education resources available for Rilex?

A: Yes, patient education information for the active ingredient is available directly through authoritative government sources, including the National Institutes of Health (NIH) MedlinePlus and official regulatory agency prescribing documents.


Q: Does the effectiveness of Rilex decrease over time?

A: Official labeling notes that the effectiveness of the medication for use longer than four months has not been assessed in clinical studies, which suggests long-term efficacy is not formally established in the available evidence.


Q: Can Rilex interact with herbal supplements like St. John's Wort?

A: Official warnings and documents state that co-administration with the herbal supplement St. John's wort may increase CNS side effects such as drowsiness, dizziness, and confusion.


Q: Is it possible to take too much Rilex?

A: Taking more than the prescribed dose is possible and can lead to symptoms like poor coordination, excessive sleepiness, slow or irregular heartbeat, and muscle weakness. The official overdosage information indicates that any suspected overdose necessitates immediate professional medical intervention.


Q: Does Rilex interact with common vitamins or mineral supplements?

A: Regulatory guidance does not document clinically significant interactions between Rilex and most common multivitamins and minerals.


Q: Is Rilex generally considered a well-tolerated medication?

A: The official tolerability profile is characterized by the most frequent adverse reactions, which include common CNS effects like sedation, dizziness, weakness, and unsteadiness.


Q: Why is Rilex sometimes combined with other medications?

A: The medicine is indicated for use in conditions where co-existing symptoms are common (e.g., anxiety associated with depression) and is also indicated for use as a premedicant prior to surgical procedures, often in combination with other agents to aid in sedation.


Q: What research is currently being conducted on Rilex?

A: Ongoing research is documented on regulatory trial databases, including studies investigating its use for conditions such as Status Epilepticus (a type of seizure emergency).


Q: Does the half-life of Rilex affect how it is taken?

A: The half-life, which determines how long the active ingredient remains in the body, is a key factor used to establish the administration instructions for divided doses throughout the day.


Q: Is there a generic version of Rilex available?

A: The active ingredient in Rilex (Lorazepam) is approved by the FDA for generic production. As a result, generic versions of the medicine are widely available in various forms.


Q: Can Rilex interfere with birth control or hormone therapy?

A: Official documents note that oral contraceptives may increase the clearance rate (removal) of the active ingredient from the body, which could alter the expected pharmacological effect.

How should Rilex be stored and disposed of?

Storage and Handling

Official regulatory documents specify different storage conditions for Rilex (Lorazepam) based on its form. The tablets must be stored at Controlled Room Temperature, typically 20 C to 25 C. The oral concentrate and injectable solution forms require refrigeration (2 C to 8 C) and must be protected from light and freezing.

The medication must remain in its original container and be kept tightly closed and away from excessive heat and moisture, such as a bathroom. The oral concentrate solution must be discarded 90 days after the bottle is first opened, as defined by official stability limits.

Disposal Instructions

All forms of Rilex must be stored out of the sight and reach of children.

Disposal must follow official governmental guidelines. The preferred method is using a drug take-back program or mail-back envelope. If a take-back option is unavailable, the medicine must be removed from its container, mixed with an unappealing substance (e.g., dirt), sealed in a bag, and placed in the household trash. Do not flush Rilex down the toilet, as it is not on the official FDA Flush List.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rilex found in:

A-Z Index: